ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BIP Biofutures

7.025
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biofutures LSE:BIP London Ordinary Share GB00B12B4T47 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.025 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Result of Arbitration (2870X)

13/02/2012 9:00am

UK Regulatory


Biofutures (LSE:BIP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Biofutures Charts.

TIDMBIP

RNS Number : 2870X

Biofutures International plc

13 February 2012

13 February 2012

Biofutures International plc

("Biofutures" or the "Group")

Result of Arbitration

The Group has received the results of the arbitration entered into by its subsidiary, Zurex Corporation Sdn Bhd ("Zurex"), and JJ Lurgi Engineering Sdn Bhd ("Lurgi"). The matter before arbitration was a claim by Zurex against Lurgi for RM9.89m and a counter claim by Lurgi for RM2.87m in relation to a contract dated 26 January 2007 for the supply by Lurgi of components for the construction of a biodiesel plant (the "Contract").

The arbitrator has concluded that the contract between Zurex and Lurgi was not terminated and, as a consequence, has dismissed the claims by both parties with each side paying its own costs. The directors of Biofutures are disappointed by the outcome as the Group had received legal advice that its case would be successful. The Group and its legal advisers are reviewing the decision.

Since the value of the assets under the Contract has been impaired in prior years; no provision had been recognised in respect of the claim against Zurex; and there is no direct liability arising as a consequence of this conclusion, the arbitration decision is not expected to have any material effects on the Group's results.

Enquiries:

 
 Biofutures International plc                Tel: + 603 6203 5136 
 Joe Wong, Chief Executive Officer 
 www.biofuturesplc.com 
 
 Daniel Stewart & Company plc          Tel: + 44 (0) 20 7776 6550 
 Antony Legge / James Thomas (Nomad) 
 Colin Rowbury (Broker) 
 www.danielstewart.co.uk 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCTJMPTMBIBMLT

1 Year Biofutures Chart

1 Year Biofutures Chart

1 Month Biofutures Chart

1 Month Biofutures Chart